{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:34:17Z","timestamp":1789907657511,"version":"4.0.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.trre.2024.100897","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T06:48:09Z","timestamp":1732603689000},"page":"100897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Complement in Kidney Transplantation"],"prefix":"10.1016","volume":"39","author":[{"given":"Pooja","family":"Lokkur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Bihari","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2024.100897_bb0005","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100897_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015479","article-title":"The innate immune system and transplantation","volume":"3","author":"Farrar","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.trre.2024.100897_bb0015","series-title":"Perioperative kidney injury: principles of risk assessment, Diagnosis and Treatment","author":"Thakar","year":"2014"},{"key":"10.1016\/j.trre.2024.100897_bb0020","series-title":"Host response to biomaterials: The impact of host response on biomaterial selection","author":"Badylak","year":"2015"},{"key":"10.1016\/j.trre.2024.100897_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ajt.15844","article-title":"Mechanisms of organ transplant injury mediated by B cells and antibodies: implications for antibody-mediated rejection","volume":"20","author":"Chong","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0030","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1016\/j.molimm.2007.06.006","article-title":"The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies","volume":"44","author":"Li","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.ajkd.2015.03.040","article-title":"Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and C3 glomerulopathy: Core curriculum 2015","volume":"66","author":"Noris","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2024.100897_bb0040","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/TP.0000000000002267","article-title":"Novel approaches to block complement","volume":"102","author":"B\u00f6hmig","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 \u2013 the \u2018Swiss Army knife\u2019 of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trre.2024.100897_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0055","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ni1494","article-title":"Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells","volume":"8","author":"Phan","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0060","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s10495-010-0530-8","article-title":"Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system","volume":"15","author":"Mevorach","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.trre.2024.100897_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.trre.2024.100897_bb0070","series-title":"Therapeutic modulation of the complement system: clinical indications and emerging drug leads","author":"Lambris","year":"2020"},{"key":"10.1016\/j.trre.2024.100897_bib571","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement- MBL and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trre.2024.100897_bb0080","article-title":"The lectin pathway in renal disease: old concept and new insights","author":"da Costa Felix Poppelaars Stefan P Berger Mohamed R Daha Marc A Seelen MG","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.2004.02627.x","article-title":"The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation","volume":"138","author":"Harboe","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molimm.2009.09.005","article-title":"The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification","volume":"47","author":"Harboe","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/imr.12473","article-title":"Old dogs-new tricks: immunoregulatory properties of C3 and C5 cleavage fragments","volume":"274","author":"Verschoor","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trre.2024.100897_bb0100","doi-asserted-by":"crossref","first-page":"R259","DOI":"10.1016\/S0960-9822(98)70167-8","article-title":"The complement system","volume":"8","author":"Taylor","year":"1998","journal-title":"Curr Biol"},{"key":"10.1016\/j.trre.2024.100897_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.602277","article-title":"Hijacking factor H for complement immune evasion","volume":"12","author":"Moore","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0110","article-title":"Activation of complement pathways in kidney tissue may mediate Tubulointerstitial injury in diabetic nephropathy","volume":"9","author":"Jiang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.trre.2024.100897_bb0115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM197704072961401","article-title":"Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis","volume":"296","author":"Craddock","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100897_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/medicina56020071","article-title":"Immunological effects of a single hemodialysis treatment","volume":"56","author":"Angeletti","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.trre.2024.100897_bb0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1681\/ASN.V101128","article-title":"Novel C5-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes","volume":"10","author":"Rosenkranz","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100897_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jcp.47.2.155","article-title":"Complement activation by cellulosic dialysis membranes","volume":"47","author":"Innes","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trre.2024.100897_bb0135","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1681\/ASN.V281328","article-title":"Modulation of complement activation on hemodialysis membranes by immobilized heparin","volume":"2","author":"Cheung","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100897_bb0140","first-page":"20","article-title":"Renal ischemia\/reperfusion injury; from pathophysiology to treatment","volume":"4","author":"Malek","year":"2015","journal-title":"J Renal Inj Prev"},{"key":"10.1016\/j.trre.2024.100897_bb0145","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.16580","article-title":"\u2018Time is tissue\u2019-a minireview on the importance of donor nephrectomy, donor hepatectomy, and implantation times in kidney and liver transplantation","volume":"21","author":"Heylen","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0150","doi-asserted-by":"crossref","DOI":"10.1096\/fj.05-4747com","article-title":"Local extravascular pool of C3 is a determinant of postischemic acute renal failure","author":"Farrar","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.trre.2024.100897_bb0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vph.2017.09.002","article-title":"Regulation and function of endothelial glycocalyx layer in vascular diseases","volume":"100","author":"Sieve","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.trre.2024.100897_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050791","article-title":"The Complement System in Kidney Transplantation","volume":"12","author":"Santarsiero","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.trre.2024.100897_bb0165","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.172.6.3869","article-title":"Critical protection from renal ischemia reperfusion injury by CD55 and CD59","volume":"172","author":"Yamada","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0170","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.4049\/jimmunol.1601943","article-title":"Overexpression of human CD55 and CD59 or treatment with human CD55 protects against renal ischemia-reperfusion injury in mice","volume":"198","author":"Bongoni","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0175","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1681\/ASN.2005070698","article-title":"Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia\/reperfusion injury","volume":"17","author":"Thurman","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100897_bb0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/eji.201747240","article-title":"Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM","volume":"48","author":"Goetz","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0185","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1073\/pnas.1101748108","article-title":"Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia\/reperfusion injury","volume":"108","author":"Schwaeble","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trre.2024.100897_bb0190","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/TP.0000000000000500","article-title":"Hypoxia and complement-and-coagulation pathways in the deceased organ donor as the major target for intervention to improve renal allograft outcome","volume":"99","author":"Damman","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2016.11.004","article-title":"Complement-mediated inflammation and injury in brain dead organ donors","volume":"84","author":"Poppelaars","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0200","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.transproceed.2018.02.157","article-title":"Functional activity of the complement system in deceased donors in relation to kidney allograft outcome","volume":"50","author":"Bartoszek","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100897_bb0205","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/ajt.12130","article-title":"Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction","volume":"13","author":"van Werkhoven","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0210","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2215\/CJN.02200312","article-title":"Clinical analysis of perioperative complement activity during ischemia\/reperfusion injury following renal transplantation","volume":"7","author":"B\u0142ogowski","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100897_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.trim.2011.03.001","article-title":"Targeting complement activation in brain-dead donors improves renal function after transplantation","volume":"24","author":"Damman","year":"2011","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0220","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/ajt.15777","article-title":"Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation","volume":"20","author":"Danobeitia","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/TP.0000000000000136","article-title":"A comparison of inflammatory, cytoprotective and injury gene expression profiles in kidneys from brain death and cardiac death donors","volume":"98","author":"Saat","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0230","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/SLA.0000000000003515","article-title":"The neglectable impact of delayed graft function on long-term graft survival in kidneys donated after circulatory death associates with superior organ resilience","volume":"270","author":"de Kok","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2024.100897_bb0235","doi-asserted-by":"crossref","first-page":"635","DOI":"10.6002\/ect.2020.0425","article-title":"Systemic complement activation in donation after brain death versus donation after circulatory death organ donors","volume":"19","author":"Halpern","year":"2021","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0240","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nm0602-582","article-title":"Local synthesis of complement component C3 regulates acute renal transplant rejection","volume":"8","author":"Pratt","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2024.100897_bb0245","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4049\/jimmunol.176.6.3330","article-title":"Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype","volume":"176","author":"Peng","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811696","article-title":"Role of complement system in kidney transplantation: stepping from animal models to clinical application","volume":"13","author":"Qi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-3046.2011.01599.x","article-title":"Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss","volume":"16","author":"Sutherland","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0260","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/TP.0000000000000699","article-title":"C1q binding activity of De novo donor-specific HLA antibodies in renal transplant recipients with and without antibody-mediated rejection","volume":"99","author":"Yell","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0265","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100897_bb0270","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.kint.2018.03.015","article-title":"Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection","volume":"94","author":"Viglietti","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2024.100897_bb0275","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0280","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.4049\/jimmunol.1000522","article-title":"Complement-dependent transport of antigen into B cell follicles","volume":"185","author":"Gonzalez","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655753","article-title":"A novel image analysis approach reveals a role for complement receptors 1 and 2 in follicular dendritic cell organization in germinal centers","volume":"12","author":"Anania","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0290","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1096\/fj.201902397R","article-title":"In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells","volume":"34","author":"Shivshankar","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.trre.2024.100897_bb0295","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1038\/s41467-021-25745-7","article-title":"C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates","volume":"12","author":"Schmitz","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.trre.2024.100897_bb0300","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","article-title":"De novo thrombotic microangiopathy after kidney transplantation","volume":"32","author":"Garg","year":"2018","journal-title":"Transplant Rev"},{"key":"10.1016\/j.trre.2024.100897_bb0305","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2024.100897_bb0310","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MNH.0b013e3283378f25","article-title":"Thrombotic microangiopathy: new insights","volume":"19","author":"Benz","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.trre.2024.100897_bb0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/his.13855","article-title":"Clinical-pathological correlations in post-transplant thrombotic microangiopathy","volume":"75","author":"Broecker","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.trre.2024.100897_bb0320","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ajt.2024.01.029","article-title":"De novo thrombotic microangiopathy after kidney transplantation in adults: interplay between complement genetics and multiple endothelial injury","volume":"24","author":"Dessaix","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0325","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3389\/fimmu.2019.02306","article-title":"Therapeutic modulation of the complement system in kidney transplantation: clinical indications and emerging drug leads","volume":"10","author":"Tatapudi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0330","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3389\/fimmu.2019.02380","article-title":"The role of complement in organ transplantation","volume":"10","author":"Grafals","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0335","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.3389\/fimmu.2019.02528","article-title":"Blocking complement factor B activation reduces renal injury and inflammation in a rat brain death model","volume":"10","author":"Jager","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0340","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1159\/000494014","article-title":"Is early complement activation in renal transplantation associated with later graft outcome?","volume":"43","author":"Bobka","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.trre.2024.100897_bb0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-022-00567-1","article-title":"Complement inhibition in kidney transplantation: where are we now?","volume":"37","author":"Vonbrunn","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.trre.2024.100897_bb0365","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0455","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1111\/ajt.14767","article-title":"A phase I\/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients","volume":"18","author":"Jordan","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0460","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2215\/CJN.04840419","article-title":"Three-year outcomes of a randomized, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients","volume":"15","author":"Huang","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100897_bb0490","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13063-017-1972-x","article-title":"A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial","volume":"18","author":"Kassimatis","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.trre.2024.100897_bb0495","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/ajt.16265","article-title":"Ex vivo delivery of Mirococept: a dose-finding study in pig kidney after showing a low dose is insufficient to reduce delayed graft function in human kidney","volume":"21","author":"Kassimatis","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0370","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/ajt.15175","article-title":"Long-term outcomes of eculizumab-treated positive crossmatch recipients: allograft survival, histologic findings, and natural history of the donor-specific antibodies","volume":"19","author":"Schinstock","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0375","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/ajt.15397","article-title":"Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies","volume":"19","author":"Glotz","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0465","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/TP.0000000000000592","article-title":"A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0470","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1111\/ajt.13871","article-title":"Plasma-derived C1 esterase inhibitor for acute antibody-mediated rejection following kidney transplantation: results of a randomized double-blind placebo-controlled pilot study","volume":"16","author":"Montgomery","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0555","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/ajt.13663","article-title":"C1 inhibitor in acute antibody-mediated rejection nonresponsive to conventional therapy in kidney transplant recipients: a pilot study","volume":"16","author":"Viglietti","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0350","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100897_bb0355","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ajt.15580","article-title":"Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: results of two randomized controlled pilot trials","volume":"20","author":"Schr\u00f6ppel","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0360","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13129","article-title":"A prospective randomized, controlled trial of eculizumab to prevent ischemia-reperfusion injury in pediatric kidney transplantation","volume":"22","author":"Kaabak","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0380","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/TP.0000000000002639","article-title":"Use of Eculizumab for active antibody-mediated rejection that occurs early post-kidney transplantation: a consecutive series of 15 cases","volume":"103","author":"Tan","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0385","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ekir.2018.11.010","article-title":"Eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome","volume":"4","author":"Siedlecki","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.trre.2024.100897_bb0390","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1111\/ajt.15364","article-title":"Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: a randomized trial","volume":"19","author":"Marks","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0395","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic\u2013Uremic Syndrome","volume":"368","author":"Legendre","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100897_bb0400","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2024.100897_bb0405","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12882-017-0802-4","article-title":"Treating C3 glomerulopathy with eculizumab","volume":"19","author":"Welte","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2024.100897_bb0410","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2024.100897_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100855","article-title":"Ravulizumab in atypical hemolytic uremic syndrome: an analysis of 2-year efficacy and safety outcomes in 2 phase 3 trials","volume":"6","author":"Dixon","year":"2024","journal-title":"Kidney Med"},{"key":"10.1016\/j.trre.2024.100897_bb0420","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-019-01068-2","article-title":"First global approval","volume":"79","author":"Ravulizumab","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2024.100897_bb0425","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2020-141787","article-title":"A novel pH dependent C5 monoclonal antibody with better developability","volume":"136","author":"Cheng","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.trre.2024.100897_bb0430","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.2019003399","article-title":"The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria","volume":"135","author":"R\u00f6th","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.trre.2024.100897_bb0435","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40265-024-02032-5","article-title":"First approval","volume":"84","author":"Crovalimab","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2024.100897_bb0440","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2021-152306","article-title":"Two currently recruiting randomized phase III trials: COMMODORE 1 and 2 evaluating crovalimab vs eculizumab in patients with paroxysmal nocturnal hemoglobinuria with or without current anti-complement therapy","volume":"138","author":"Kulasekararaj","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.trre.2024.100897_bb0445","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.molimm.2008.06.028","article-title":"Biological activities of C1 inhibitor","volume":"45","author":"Davis","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0450","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.molimm.2013.01.009","article-title":"The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while \u03b12-macroglobulin is not","volume":"54","author":"Par\u00e9j","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0475","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/TP.0000000000002717","article-title":"Update on C1 esterase inhibitor in human solid organ transplantation","volume":"103","author":"Berger","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.984090","article-title":"Complement-targeted therapies in kidney transplantation-insights from preclinical studies","volume":"13","author":"Anwar","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100897_bb0485","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/ajt.14528","article-title":"Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial","volume":"18","author":"Eskandary","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100897_bb0500","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/TP.0000000000003496","article-title":"Imlifidase desensitization in crossmatch-positive, highly sensitized kidney transplant recipients: results of an international phase 2 trial (highdes): results of an international phase 2 trial (Highdes)","volume":"105","author":"Jordan","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0505","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.immuni.2013.02.023","article-title":"Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation","volume":"38","author":"Heesters","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.trre.2024.100897_bb0510","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00007890-199304000-00033","article-title":"Prolongation of cardiac xenograft survival by depletion of complement","volume":"55","author":"Leventhal","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0515","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nm1330","article-title":"Acute rejection is associated with antibodies to non-gal antigens in baboons using gal-knockout pig kidneys","volume":"11","author":"Chen","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2024.100897_bb0520","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/TP.0b013e318203c27d","article-title":"Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation","volume":"91","author":"Byrne","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0525","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12967-024-05136-4","article-title":"Complement networks in gene-edited pig xenotransplantation: enhancing transplant success and addressing organ shortage","volume":"22","author":"Yuan","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.trre.2024.100897_bb0530","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12262","article-title":"Complement C3 inhibitor Cp40 attenuates xenoreactions in pig hearts perfused with human blood","volume":"24","author":"Abicht","year":"2017","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.trre.2024.100897_bb0535","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.2010.75","article-title":"Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons","volume":"78","author":"Tillou","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2024.100897_bb0540","series-title":"Complement-mediated enhancement of monocyte ad- hesion to endothelial cells by HLA antibodies, and blockade by a specific inhibitor of the classical complement cascade","author":"Valenzuela","year":"2024"},{"key":"10.1016\/j.trre.2024.100897_bb0545","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000006529","article-title":"The time has come: the case for initiating pilot clinical trials of pig kidney xenotransplantation","author":"Cooper","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2024.100897_bb0550","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0140-6736(23)01349-1","article-title":"Immune response after pig-to-human kidney xenotransplantation: a multimodal phenotyping study","volume":"402","author":"Loupy","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2024.100897_bb0560","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jmb.2012.02.038","article-title":"Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d","volume":"418","author":"Li","year":"2012","journal-title":"J Mol Biol"},{"key":"10.1016\/j.trre.2024.100897_bb0565","doi-asserted-by":"crossref","first-page":"10346","DOI":"10.1038\/s41598-018-28724-z","article-title":"Cobra venom factor-induced complement depletion protects against lung ischemia reperfusion injury through alleviating blood-air barrier damage","volume":"8","author":"Haihua","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.trre.2024.100897_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100823","article-title":"Factor B inhibition with Iptacopan in recurrent C3 Glomerulopathy following kidney transplant: a report of two cases","volume":"6","author":"Escudero-Saiz","year":"2024","journal-title":"Kidney Med"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X24000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X24000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:13:38Z","timestamp":1736226818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X24000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0955470X24000806"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2024.100897","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement in Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2024.100897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100897"}}